Specialty Pharmacy

Virus was undetectable for 3 years before researchers discovered viral reservoirs have not disappeared.

World Health Organization officials are stressing that clinical trials on Ebola vaccine candidates need to be expedited.

Howard Barsky, chief information officer for Armada Health Care, discusses how specialty pharmacies can improve services for patients through the use of data analytics.

Researchers in Finland are learning more about how hormones influence the risk of developing breast cancer, which may lead to a hormone-based treatment to reduce the risk of developing cancer later in life.

The child showed no symptoms of the respiratory virus prior to his death.

Findings of study provide new options for future vaccine development.

Authorities are homing in on those who may have been in contact with a Liberian national who traveled to Dallas while infected with the Ebola virus.

Patients who smoke both traditional and e-cigarettes less likely to quit than those who only smoke traditional cigarettes.

Sleep disorders may require independent diagnosis and management, researchers say.

Texas health care officials have ordered close relatives of the Dallas Ebola patient to stay home.

Investigators aim to reduce side effects of therapy with sofosbuvir in children with hepatitis C.

Evolocumab cut low-density lipoprotein cholesterol levels by 60%, on average, in patients with heterozygous familial hypercholesterolemia

Gilead has refined the pharmacokinetics of tenofovir disoproxil fumarate (TDF), an anchor drug in several single-tablet medications for HIV-1, to create tenofovir alafenamide (TAF). Phase II results indicate superior renal outcomes and equivalent clinical outcomes with TAF versus TDF.

Four children who recently died have tested positive for enterovirus D68, though it is not yet clear what role, if any, the virus played in their deaths.

A metaanalysis shows that levels of an antioxidative endogenous metabolic byproduct-uric acid-are correlated with disease activity in multiple sclerosis.

Officials stress that the strength of the US health care system will contain the virus.

A new metaanalysis suggests that quitting smoking, or even reducing tobacco intake, reduces the risk of dying from prostate cancer.

As the Ebola outbreak worsens, interest in therapies using recovered victims' blood grows.

Michael Nameth, RPh, MBA, chief executive officer of Aureus Health Services, discusses the major hurdles facing mid-size specialty pharmacies.

The current Ebola epidemic is causing the health care system in West Africa to collapse.

A combination of vemurafenib (Zelboraf) and experimental drug cobimetinib significantly reduces the development of secondary skin cancer.

Adding panobinostat to a combination treatment of bortezomib and dexamethasone in heavily pretreated patients boosts progression-free survival, but overall survival data are not yet mature.

In a recent phase III trial, a 3-medication regimen showed efficacy in reducing treatment-related nausea and vomiting in patients with multiple myeloma undergoing induction therapy before autologous stem cell transplant.

Obama calls for international response to prevent "humanitarian catastrophe."

A combination of Lactobacillus plantarum and a modified inulin derivative reduced expression of T-cells in mammary cancers induced in rats.

A recent metaanalysis suggests that prediabetes increases the risk of developing certain cancers, particularly in tissues located near the gastrointestinal tract.

RX-3117 maintains anti-tumor activity in cancer cell lines that are resistant to gemcitabine.